Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Radiologia (Engl Ed) ; 64(5): 484-488, 2022.
Article in English | MEDLINE | ID: mdl-36243448

ABSTRACT

Melioidosis is an endemic disease in Southeast Asia and Oceania caused by the gram-negative bacillus Burkholderia pseudomallei. We studied 15 adult patients from Colombia with microbiologically diagnosed pulmonary melioidosis. We reviewed 15 chest X-rays and 10 chest computed tomography (CT) studies. Of the 15 patients, 87% met the criteria for acute infection and 13% met the criteria for chronic infection. The most common findings on chest X-rays were consolidation (86%), nodules (26%), and cavitation (20%). On CT studies, consolidation and nodules were observed in 90% of cases; the areas of consolidation were predominantly located in the basal and central zones in 60%. Areas of cavitation were observed in 50%, pleural effusion in 60%, and mediastinal lymph nodes in 30%. In patients with acute pulmonary melioidosis (n=8), the findings observed were nodules (100%), mixed pattern with nodules and consolidation (87%), pleural effusion (88%), and mediastinal lymph nodes (25%). The two patients with chronic pulmonary melioidosis both had cavitation. Acute lung infection with B. Pseudomallei has radiologic manifestations similar to those of pneumonia due to other causes. In areas where the disease is endemic, it is essential to include acute melioidosis in the differential diagnosis of pulmonary nodules and chronic melioidosis in the differential diagnosis of cavitated chronic lung lesions.


Subject(s)
Burkholderia pseudomallei , Lung Diseases , Melioidosis , Pleural Effusion , Pneumonia , Tuberculosis, Pleural , Adult , Humans , Lung Diseases/diagnostic imaging , Melioidosis/diagnostic imaging , Melioidosis/epidemiology , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology
2.
Radiología (Madr., Ed. impr.) ; 64(5): 484-488, Sep.-Oct. 2022. ilus, tab
Article in Spanish | IBECS | ID: ibc-209924

ABSTRACT

La melioidosis es una enfermedad endémica en el suroeste asiático y Oceanía y está causada por la infección por el bacilo gramnegativo Burkholderia pseudomallei. Se estudian 15 pacientes adultos de Colombia con diagnóstico microbiológico de melioidosis pulmonar. Se revisaron 15 radiografías de tórax y 10 tomografías computarizadas (TC) de tórax. De los 15 pacientes, el 87% tenía criterios de infección aguda y el 13%, de infección crónica. Los hallazgos más frecuentes en la radiografía de tórax fueron: consolidación (86%), nódulos (26%) y cavitación (20%). En la tomografía computarizada se encontraron áreas de consolidación y nódulos en el 90% de los casos. En el 60% de los pacientes, las áreas de consolidación fueron de predominio basal y central. En el 50% de los casos se evidenciaron áreas de cavitación. Se evidenció derrame pleural en el 60% y adenopatías mediastínicas en el 30% de los casos. En los pacientes con presentación aguda (n=8), los hallazgos visualizados incluyeron: nódulos (100%), patrón mixto con nódulos y consolidación (87%), derrame pleural (88%) y adenopatías mediastínicas (25%). Los pacientes con melioidosis crónica (n=2) presentaron cavitación. La infección pulmonar aguda por B. Pseudomallei cursa con manifestaciones radiológicas similares a neumonías de otra etiología. En zonas endémicas debe considerarse la posibilidad de melioidosis aguda en el diagnóstico diferencial de nódulos pulmonares, y de melioidosis crónica en el diagnóstico diferencial de lesiones pulmonares crónicas cavitadas.(AU)


Melioidosis is an endemic disease in Southeast Asia and Oceania caused by the gram-negative bacillus Burkholderia pseudomallei. We studied 15 adult patients from Colombia with microbiologically diagnosed pulmonary melioidosis. We reviewed 15 chest X-rays and 10 chest computed tomography (CT) studies. Of the 15 patients, 87% met the criteria for acute infection and 13% met the criteria for chronic infection. The most common findings on chest X-rays were consolidation (86%), nodules (26%), and cavitation (20%). On CT studies, consolidation and nodules were observed in 90% of cases; the areas of consolidation were predominantly located in the basal and central zones in 60%. Areas of cavitation were observed in 50%, pleural effusion in 60%, and mediastinal lymph nodes in 30%. In patients with acute pulmonary melioidosis (n=8), the findings observed were nodules (100%), mixed pattern with nodules and consolidation (87%), pleural effusion (88%), and mediastinal lymph nodes (25%). The two patients with chronic pulmonary melioidosis both had cavitation. Acute lung infection with B. Pseudomallei has radiologic manifestations similar to those of pneumonia due to other causes. In areas where the disease is endemic, it is essential to include acute melioidosis in the differential diagnosis of pulmonary nodules and chronic melioidosis in the differential diagnosis of cavitated chronic lung lesions.(AU)


Subject(s)
Humans , Male , Female , Melioidosis/diagnostic imaging , Melioidosis/diagnosis , Tomography, X-Ray Computed , Radiography, Thoracic , Diagnosis, Differential , Inpatients , Burkholderia pseudomallei , Pneumonia , Colombia , Radiology , Diagnostic Imaging , Retrospective Studies , Medical Records , Incidental Findings
3.
EClinicalMedicine ; 43: 101242, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34957385

ABSTRACT

BACKGROUND: The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The objective of this study was to assess the effectiveness and safety of rosuvastatin plus colchicine, emtricitabine/tenofovir, and their combined use in these patients. METHODS: This was a randomized, controlled, open-label, multicentre, parallel, pragmatic study conducted in six referral hospitals in Bogotá, Colombia. The study enrolled hospitalized patients over 18 years of age with a confirmed diagnosis of COVID-19 complicated with pneumonia, not on chronic treatment with the study medications, and with no contraindications for their use. Patients were assigned 1:1:1:1. 1) emtricitabine with tenofovir disoproxil fumarate (FTC/TDF, 200/300 mg given orally for 10 days); 2) colchicine plus rosuvastatin (COLCH+ROSU, 0.5 mg and 40 mg given orally for 14 days); 3) emtricitabine with tenofovir disoproxil plus colchicine and rosuvastatin at the same doses and for the same period of time (FTC/TDF+COLCH+ROSU); or 4) the Colombian consensus standard of care, including a corticosteroid (SOC). The primary endpoint was 28-day all-cause mortality. A modified intention-to-treat analysis was used together with a usefulness analysis to determine which could be the best treatment. The trial was registered at ClinicalTrials.gov: NCT04359095. FINDINGS: Out of 994 candidates considered between August 2020 and March 2021, 649 (65.3%) patients agreed to participate and were enrolled in this study; among them, 633 (97.5%) were included in the analysis. The mean age was 55.4 years (SD ± 12.8 years), and 428 (68%) were men; 28-day mortality was significantly lower in the FTC/TDF+COLCH+ROSUV group than in the SOC group, 10.7% (17/159) vs. 17.4% (28/161) (hazard ratio [HR] 0.53; 95% CI 0.29 to 0.96). Mortality in the FTC/TDF group was 13.8% (22/160, HR 0.68, 95% CI 0.39 to 1.20) and 14.4% in the COLCH+ROSU group (22/153) (HR 0.78, 95% CI 0.44 to 1.36). A lower need for invasive mechanical ventilation was observed in the FTC/TDF+COLCH+ROSUV group than in the SOC group (risk difference [RD] - 0.08, 95% CI 0.11 to 0.04). Three patients presented severe adverse events, one severe diarrhoea in the COLCH+ROSU and one in the FTC/TDF+COLCH+ROSU group and one general exanthema in the FTC/TDF group. INTERPRETATION: The combined use of FTC/TDF+COLCH+ROSU reduces the risk of 28-day mortality and the need for invasive mechanical ventilation in hospitalized patients with pulmonary compromise from COVID-19. More randomized controlled trials are needed to compare the effectiveness and cost of treatment with this combination versus other drugs that have been shown to reduce mortality from SARS-CoV-2 infection and its usefulness in patients with chronic statin use.

4.
Radiologia (Engl Ed) ; 2021 May 24.
Article in English, Spanish | MEDLINE | ID: mdl-34045076

ABSTRACT

Melioidosis is an endemic disease in Southeast Asia and Oceania caused by the gram-negative bacillus Burkholderia pseudomallei. We studied 15 adult patients from Colombia with microbiologically diagnosed pulmonary melioidosis. We reviewed 15 chest X-rays and 10 chest computed tomography (CT) studies. Of the 15 patients, 87% met the criteria for acute infection and 13% met the criteria for chronic infection. The most common findings on chest X-rays were consolidation (86%), nodules (26%), and cavitation (20%). On CT studies, consolidation and nodules were observed in 90% of cases; the areas of consolidation were predominantly located in the basal and central zones in 60%. Areas of cavitation were observed in 50%, pleural effusion in 60%, and mediastinal lymph nodes in 30%. In patients with acute pulmonary melioidosis (n=8), the findings observed were nodules (100%), mixed pattern with nodules and consolidation (87%), pleural effusion (88%), and mediastinal lymph nodes (25%). The two patients with chronic pulmonary melioidosis both had cavitation. Acute lung infection with B. Pseudomallei has radiologic manifestations similar to those of pneumonia due to other causes. In areas where the disease is endemic, it is essential to include acute melioidosis in the differential diagnosis of pulmonary nodules and chronic melioidosis in the differential diagnosis of cavitated chronic lung lesions.

5.
Infection ; 40(5): 517-26, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22711598

ABSTRACT

PURPOSE: We aimed to evaluate the impact of a multidimensional infection control strategy for the reduction of the incidence of catheter-associated urinary tract infection (CAUTI) in patients hospitalized in adult intensive care units (AICUs) of hospitals which are members of the International Nosocomial Infection Control Consortium (INICC), from 40 cities of 15 developing countries: Argentina, Brazil, China, Colombia, Costa Rica, Cuba, India, Lebanon, Macedonia, Mexico, Morocco, Panama, Peru, Philippines, and Turkey. METHODS: We conducted a prospective before-after surveillance study of CAUTI rates on 56,429 patients hospitalized in 57 AICUs, during 360,667 bed-days. The study was divided into the baseline period (Phase 1) and the intervention period (Phase 2). In Phase 1, active surveillance was performed. In Phase 2, we implemented a multidimensional infection control approach that included: (1) a bundle of preventive measures, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback of CAUTI rates, and (6) feedback of performance. The rates of CAUTI obtained in Phase 1 were compared with the rates obtained in Phase 2, after interventions were implemented. RESULTS: We recorded 253,122 urinary catheter (UC)-days: 30,390 in Phase 1 and 222,732 in Phase 2. In Phase 1, before the intervention, the CAUTI rate was 7.86 per 1,000 UC-days, and in Phase 2, after intervention, the rate of CAUTI decreased to 4.95 per 1,000 UC-days [relative risk (RR) 0.63 (95% confidence interval [CI] 0.55-0.72)], showing a 37% rate reduction. CONCLUSIONS: Our study showed that the implementation of a multidimensional infection control strategy is associated with a significant reduction in the CAUTI rate in AICUs from developing countries.


Subject(s)
Catheter-Related Infections/epidemiology , Cross Infection/epidemiology , Infection Control/methods , Urinary Tract Infections/epidemiology , Americas/epidemiology , Asia/epidemiology , Catheter-Related Infections/prevention & control , Cross Infection/prevention & control , Developing Countries/statistics & numerical data , Europe/epidemiology , Female , Hand Hygiene/statistics & numerical data , Humans , Male , Middle Aged , Morocco/epidemiology , Program Evaluation , Prospective Studies , Urinary Catheters/statistics & numerical data , Urinary Tract Infections/prevention & control
6.
Rev Inst Med Trop Sao Paulo ; 41(4): 229-34, 1999.
Article in English | MEDLINE | ID: mdl-10564916

ABSTRACT

This study was carried out in order to obtain base-line data concerning the epidemiology of American Visceral Leishmaniasis and Chagas' Disease in an indigenous population with whom the government is starting a dwelling improvement programme. Information was collected from 242 dwellings (1,440 people), by means of house to house interviews about socio-economic and environmental factors associated with Leishmania chagasi and Trypanosoma cruzi transmission risk. A leishmanin skin test was applied to 385 people and 454 blood samples were collected on filter paper in order to detect L. chagasi antibodies by ELISA and IFAT and T. cruzi antibodies by ELISA. T. cruzi seroprevalence was 8.7% by ELISA, L. chagasi was 4.6% and 5.1% by IFAT and ELISA, respectively. ELISA sensitivity and specificity for L. chagasi antibodies were 57% and 97.5% respectively, as compared to the IFAT. Leishmanin skin test positivity was 19%. L. chagasi infection prevalence, being defined as a positive result in the three-immunodiagnostic tests, was 17.1%. Additionally, 2.7% of the population studied was positive to both L. chagasi and T. cruzi, showing a possible cross-reaction. L. chagasi and T. cruzi seropositivity increased with age, while no association with gender was observed. Age (p<0.007), number of inhabitants (p<0. 05), floor material (p<0.03) and recognition of vector (p<0.01) were associated with T. cruzi infection, whilst age ( p<0.007) and dwelling improvement (p<0.02) were associated with L. chagasi infection. It is necessary to evaluate the long-term impact of the dwelling improvement programme on these parasitic infections in this community.


Subject(s)
Chagas Disease/epidemiology , Leishmania , Leishmaniasis, Visceral/epidemiology , Trypanosoma cruzi , Adult , Aged , Animals , Chagas Disease/transmission , Colombia/epidemiology , Disease Vectors , Dogs , Housing , Humans , Leishmaniasis, Visceral/transmission , Middle Aged , Risk Factors , Sensitivity and Specificity , Seroepidemiologic Studies
7.
Eur J Clin Nutr ; 46(7): 527-33, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1623857

ABSTRACT

Interleukin-1 (IL-1) is a cytokine produced by the macrophage-monocyte system that has important effects on immunological responses and inflammatory reactions. Several clinical studies have shown that severe protein energy malnutrition adversely effects cell-mediated immune responses and the functional state of macrophages. The objective of this study was to analyse IL-1 production by adherent cells stimulated in vitro with lipopolysaccharide B (LPS) from patients with alcoholic cirrhosis of the liver and its possible relationship with nutritional states. Forty-five patients with alcoholic cirrhosis and 28 healthy donors were investigated. A combined index of nine anthropometric and biochemical parameters was used to evaluate nutritional status of cirrhotic patients, allowing a distinction to be made between those patients with acceptable nutrition (group I: 40%), those with slight malnutrition (group II: 37.7%), and those with severe malnutrition (group III: 22.3%). IL-1 activity was significantly lower in the cirrhosis patients than in the controls (P less than 0.001). This activity also was significantly lower in samples obtained from cirrhotics with severe malnutrition than in those with acceptable nutrition (P less than 0.05); the combined index and the sole anthropometric index gave the same results, suggesting that malnutrition may play a role in the immunoregulatory disturbances in the pathogenesis of alcoholic liver disease.


Subject(s)
Interleukin-1/biosynthesis , Liver Cirrhosis, Alcoholic/metabolism , Nutritional Status , Adult , Aged , Anthropometry , Blood Proteins/chemistry , Cells, Cultured , Data Interpretation, Statistical , Female , Humans , Lipopolysaccharides/metabolism , Liver Cirrhosis, Alcoholic/complications , Male , Middle Aged , Monocytes/metabolism , Nutrition Disorders/etiology , Nutrition Disorders/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...